Shell Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,873
| Closed | -$410K | – | 1304 |
|
|
2023
Q1 | $410K | Hold |
1,873
| – | – | 0.02% | 655 |
|
|
2022
Q4 | $390K | Sell |
1,873
-626
| -25% | -$138K | 0.02% | 661 |
|
|
2022
Q3 | $546K | Sell |
2,499
-384
| -13% | -$87.4K | 0.02% | 533 |
|
|
2022
Q2 | $604K | Buy |
2,883
+133
| +5% | +$28.3K | 0.02% | 615 |
|
|
2022
Q1 | $667K | Sell |
2,750
-439
| -14% | -$106K | 0.02% | 664 |
|
|
2021
Q4 | $831K | Buy |
3,189
+924
| +41% | +$240K | 0.02% | 655 |
|
|
2021
Q3 | $597K | Sell |
2,265
-10,885
| -83% | -$2.98M | 0.01% | 787 |
|
|
2021
Q2 | $3.24M | Buy |
13,150
+5,815
| +79% | +$1.22M | 0.06% | 281 |
|
|
2021
Q1 | $1.42M | Sell |
7,335
-8,589
| -54% | -$1.72M | 0.03% | 430 |
|
|
2020
Q4 | $3.38M | Sell |
15,924
-7,570
| -32% | -$1.51M | 0.07% | 295 |
|
|
2020
Q3 | $4.03M | Buy |
23,494
+3,240
| +16% | +$598K | 0.09% | 216 |
|
|
2020
Q2 | $3.89M | Buy |
20,254
+4,661
| +30% | +$763K | 0.1% | 216 |
|
|
2020
Q1 | $2.3M | Sell |
15,593
-519
| -3% | -$82.7K | 0.06% | 285 |
|
|
2019
Q4 | $2.5M | Sell |
16,112
-11,310
| -41% | -$1.63M | 0.05% | 335 |
|
|
2019
Q3 | $3.71M | Sell |
27,422
-2,347
| -8% | -$307K | 0.08% | 259 |
|
|
2019
Q2 | $3.63M | Sell |
29,769
-965
| -3% | -$107K | 0.08% | 262 |
|
|
2019
Q1 | $3.19M | Sell |
30,734
-7,988
| -21% | -$824K | 0.07% | 285 |
|
|
2018
Q4 | $4.41M | Buy |
38,722
+2,000
| +5% | +$214K | 0.11% | 222 |
|
|
2018
Q3 | $4.24M | Sell |
36,722
-1,561
| -4% | -$171K | 0.08% | 256 |
|
|
2018
Q2 | $3.96M | Sell |
38,283
-22,540
| -37% | -$2.28M | 0.08% | 269 |
|
|
2018
Q1 | $5.99M | Buy |
60,823
+1,536
| +3% | +$145K | 0.12% | 213 |
|
|
2017
Q4 | $5.02M | Sell |
59,287
-1,903
| -3% | -$157K | 0.1% | 229 |
|
|
2017
Q3 | $4.71M | Sell |
61,190
-1,633
| -3% | -$125K | 0.1% | 223 |
|
|
2017
Q2 | $4.89M | Buy |
62,823
+500
| +0.8% | +$35.8K | 0.1% | 226 |
|
|
2017
Q1 | $4.49M | Buy |
62,323
+6,482
| +12% | +$448K | 0.1% | 228 |
|
|
2016
Q4 | $3.46M | Sell |
55,841
-9,117
| -14% | -$558K | 0.08% | 261 |
|
|
2016
Q3 | $4.21M | Sell |
64,958
-2,142
| -3% | -$143K | 0.09% | 258 |
|
|
2016
Q2 | $4.24M | Buy |
67,100
+23,548
| +54% | +$1.39M | 0.1% | 233 |
|
|
2016
Q1 | $2.52M | Sell |
43,552
-400
| -0.9% | -$22.6K | 0.06% | 313 |
|
|
2015
Q4 | $2.36M | Sell |
43,952
-27,508
| -38% | -$1.55M | 0.06% | 332 |
|
|
2015
Q3 | $3.52M | Buy |
71,460
+8,297
| +13% | +$447K | 0.06% | 295 |
|
|
2015
Q2 | $3.56M | Sell |
63,163
-9,534
| -13% | -$602K | 0.07% | 280 |
|
|
2015
Q1 | $5.22M | Sell |
72,697
-7,089
| -9% | -$460K | 0.09% | 221 |
|
|
2014
Q4 | $4.47M | Buy |
79,786
+8,326
| +12% | +$435K | 0.07% | 265 |
|
|
2014
Q3 | $3.52M | Buy |
71,460
+3,518
| +5% | +$179K | 0.05% | 306 |
|
|
2014
Q2 | $3.44M | Sell |
67,942
-10
| -0% | -$496 | 0.05% | 312 |
|
|
2014
Q1 | $3.04M | Sell |
67,952
-2
| -0% | -$90 | 0.05% | 336 |
|
|
2013
Q4 | $3.2M | Buy |
67,954
+21,258
| +46% | +$1.08M | 0.05% | 326 |
|
|
2013
Q3 | $2.47M | Sell |
46,696
-11,764
| -20% | -$571K | 0.05% | 413 |
|
|
2013
Q2 | $2.64M | Buy |
+58,460
| New | +$2.77M | 0.05% | 378 |
|
Other funds holding RMD
Shell Asset Management's RMD Position: Q2 2023 in Review
Shell Asset Management sold out of ResMed (RMD) in Q2 2023, closing a stake of 1,873 shares — an estimated $410K sold.
Shell Asset Management first reported a position in RMD in Q2 2013 and held it in 40 quarters. The position peaked at $5.99M in Q1 2018. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.
- Shell Asset Management reported no remaining ResMed position as of Q2 2023 after selling out during the quarter.
- Shell Asset Management sold 1,873 ResMed shares in Q2 2023, an estimated $410K.
- Shell Asset Management first reported a position in ResMed in Q2 2013 and held it in 40 quarters.
- Shell Asset Management's ResMed position peaked at $5.99M in Q1 2018.
- 731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.
Based on Shell Asset Management's 13F filing for Q2 2023, filed 28 Jul 2023.